Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

111.30 USD +1.26 (+1.15%)
Official Closing Price Updated: 7:55 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Abbott Laboratories

< Previous 1 2 3 4 5 6 7 8 9
...
74 75 Next >
Absolute Protects Patient Data and Supports HIPAA Compliance for Apria Healthcare
To ensure the highest levels of endpoint security across more than 8,000 devices and to help achieve HIPAA compliance in the face of rising data breaches across the healthcare industry, Apria... 
From Business Wire News Releases
Abbott to Initiate Trial to Study MitraClip as an Option for Moderate Surgical Risk Patients
- New clinical trial will assess first-of-its-kind MitraClip™ transcatheter mitral valve repair against current standard of care surgery in a new, expanded patient population 
From PR Newswire
FDA Approves Less Invasive Surgical Approach for Abbott's Heart Pump to Help Patients Avoid Open Heart Surgery
- For people battling advanced heart failure, Abbott's HeartMate 3 heart pump can now be implanted through an incision in the chest wall versus open heart surgery 
From PR Newswire
Absolute Appoints Dianne Lapierre as Chief Information Officer
Absolute (TSX: ABT), the leader in endpoint resilience, today announced Dianne Lapierre has joined Absolute as Chief Information Officer. Ms. Lapierre will report directly to Absolute CEO, Christy... 
From Business Wire News Releases
Absolute to Present at the 22nd Annual Needham Growth Conference
Absolute® (TSX:ABT), the leader in endpoint resilience, today announced that Christy Wyatt, Chief Executive Officer, will be presenting at the 22nd Annual Needham Growth Conference in New York. Joining... 
From Business Wire News Releases
Abbott Hosts Conference Call for Fourth-Quarter Earnings
Abbott (NYSE: ABT) will announce its fourth-quarter 2019 financial results on Wednesday, Jan. 22, 2020, before the market opens. 
From PR Newswire
Abbott Raises Quarterly Dividend 12.5%, Increasing Payouts for 48 Straight Years
The board of directors of Abbott (NYSE: ABT) today increased the company's quarterly common dividend to 36 cents per share – a 12.5% increase. 
From PR Newswire
Absolute Reports AGM Voting Results
Absolute Software Corporation (ABT.TO) (“Absolute”), the leader in endpoint resilience, today announced that at its annual general meeting of shareholders held on December 11, 2019, each of the six... 
From Business Wire News Releases
Abbott Announces Robert B. Ford to Succeed Miles D. White as Chief Executive Officer on March 31, 2020
- Mr. White will remain Executive Chairman of the Board 
From PR Newswire
Absolute Reports Fiscal 2020 First Quarter Financial Results
Absolute (TSX: ABT) (“Absolute” or the “Company”), the leader in endpoint resilience, today announced its financial results for the three months ended September 30, 2019. All dollar figures are stated... 
From Business Wire News Releases
Abbott Announces Discovery of New Strain of HIV, Keeping Global Health Community a Step Ahead of the Virus
- Discovery marks the first time a new subtype of HIV-1 has been identified since 2000 
From PR Newswire
Klein Independent School District Maximizes One-to-One Program with Absolute Security and Analytics
Absolute (TSX: ABT), the leader in endpoint resilience, today announced Klein Independent School District (ISD) is leveraging Absolute’s Student Technology Analytics across its device fleet to protect... 
From Business Wire News Releases
Media Alert: Absolute to Host Fireside Chat at TD Securities 2019 Technology Conference
Absolute® (TSX:ABT), the leader in endpoint resilience, today announced that the company will be a featured participant at the TD Securities 2019 Technology Conference. Christy Wyatt, CEO of Absolute,... 
From Business Wire News Releases
Absolute to Host Conference Call for Fiscal 2020 First Quarter Financial Results
Absolute (TSX: ABT), the leader in endpoint resilience, today announced it will host a conference call on Tuesday, November 12, 2019 at 5:00 p.m. ET (2:00 p.m. PT) to discuss its fiscal 2020 first... 
From Business Wire News Releases
Absolute Appoints New Executives to Leadership Team to Accelerate Product Innovation and Enhance Endpoint Resilience Offerings
Absolute (TSX: ABT), the leader in endpoint resilience, today announced two new appointments to the company’s executive leadership team. William Morris joins as Executive Vice President, Engineering... 
From Business Wire News Releases
Absolute Declares Quarterly Dividend
Absolute (TSX: ABT), the leader in endpoint resilience, today announced that its Board of Directors has declared a quarterly dividend of CAD$0.08 per share on its common shares, payable in cash on... 
From Business Wire News Releases
The Australian Red Cross Blood Service Selects Abbott's Alinity s Solution for Blood and Plasma Screening
Abbott and the Australian Red Cross Blood Service extend 30-year partnership of providing safe, life-saving blood supply in Australia 
From PR Newswire
Absolute Named a Leader in G2 Fall 2019 Grid Report for Endpoint Management Software
Absolute (TSX: ABT), the leader in endpoint resilience, today announced the company has achieved a Leader ranking in the G2 Fall 2019 Grid Report for Endpoint Management Software. Based on high levels... 
From Business Wire News Releases
Absolute to Host Financial Analyst Day on November 13, 2019
Absolute (TSX: ABT), the leader in endpoint resilience, today announced it will host a financial analyst meeting in New York City on Wednesday November 13, 2019 starting at 12:00 P.M. Eastern time. 
From Business Wire News Releases
Abbott Reports Third-Quarter 2019 Results
- Third-quarter sales growth of 5.5 percent; organic sales growth of 7.6 percent 
From PR Newswire
Abbott and Tandem Diabetes Care Exploring New Integrated Solutions to Improve Diabetes Management
- Companies aim to integrate Abbott's FreeStyle Libre glucose sensing technology with Tandem's insulin delivery products to expand choices for people with diabetes 
From PR Newswire
Abbott and Omada Health Partner to Offer Integrated Digital Health and Coaching Experience for People with Type 2 Diabetes
- Collaboration combines Abbott′s world-leading glucose sensing technology with Omada Health's best-in-class, proprietary digital coaching platform to provide personalized, on-the-go care 
From PR Newswire
Biotechs Strive to Combat Rising Cancer Mortality Rates
FinancialBuzz.com News Commentary 
From PR Newswire
Absolute Announces Executive Departures
Absolute (TSX: ABT) today announced that Errol Olsen, Chief Financial Officer, and Todd Wakerley, Executive Vice President, Product Development, will be leaving Absolute, each for personal reasons,... 
From Business Wire News Releases
New Research from Absolute Underscores Educational Organizations Vulnerable to Cyber Attacks
Absolute (TSX: ABT), the leader in endpoint resilience, today announced the introduction of a new research report titled ”Cybersecurity and Education: The State of the Digital District in 2020,”... 
From Business Wire News Releases
Late-Breaking Data Shows Abbott's MitraClip™ is Cost Effective, Increases Life Expectancy and Improves Quality of Life
- New late-breaking data at TCT 2019 demonstrate that Abbott's MitraClip™ is cost-effective for heart failure patients with significant secondary mitral regurgitation compared to guideline-directed... 
From PR Newswire
New Data Demonstrate Strong Outcomes for Abbott Device to Repair Leaky Tricuspid Heart Valves
- New data presented at TCT 2019 on Abbott's TriClip device from the TRILUMINATE Feasibility Study met both the primary safety and performance endpoints 
From PR Newswire
Absolute Announces Renewal of Share Buyback Program
Absolute (TSX: ABT), the leader in endpoint resilience, today announced that it is proceeding with a renewed normal course issuer bid (the “Bid”) for up to 2,663,275 of its common shares (“Shares”),... 
From Business Wire News Releases
FDA Approves Abbott's "Low Dose," Recharge-Free Spinal Cord Stimulation System with up to Ten Year Battery Life* for People Living with Chronic Pain
- Proclaim™ XR neurostimulation system uses Abbott's proprietary, low energy BurstDR™ therapy coupled with the BoldXR™ low dosing protocol for safe, effective pain relief and a battery that lasts up to... 
From PR Newswire
U.S. FDA Clears Abbott's High Sensitivity Troponin-I Blood Test That Aids Doctors in Diagnosing Heart Attacks Faster and More Accurately
Newly cleared diagnostic test could help identify heart attacks several hours sooner than standard troponin tests and help improve diagnosis in women 
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
74 75 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.